Skip to Content

AptarGroup Inc

ATR: XNYS (USA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
$917.00QlgwwdhFphrhztsm

Aptar's Profitability Improving due to Pharma Growth and Cost Controls

Business Strategy and Outlook

Aptar is a global leader in dispensing technologies and operates under three business segments, Aptar Pharma, Aptar Beauty, and Aptar Closures. The company specializes in various drug dispensing solutions including nasal spray inhalers and elastomer components for injectable drugs, high-end fragrance pumps, and food dispensing closures. While Aptar’s portfolio includes lower-margin products such as shampoo and soap pumps and caps for sauce bottles, it has intentionally focused on growing the higher-margin healthcare business over the past decade, which now accounts for about two thirds of operating profits.

Free Trial of Morningstar Investor

Get our analysts’ objective, in-depth, and continuous investment coverage of ATR so you can make buy / sell decisions free of market noise.

Start Free Trial

Sponsor Center